Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1991 Aug 3;303(6797):276–282. doi: 10.1136/bmj.303.6797.276

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.

Z Chen 1, R Peto 1, R Collins 1, S MacMahon 1, J Lu 1, W Li 1
PMCID: PMC1670480  PMID: 1888927

Abstract

OBJECTIVE--To examine the relation between serum cholesterol concentration and mortality (from coronary heart disease and from other causes) below the range of cholesterol values generally seen in Western populations. DESIGN--Prospective observational study based on 8-13 years of follow up of subjects in a population with low cholesterol concentrations. SETTING--Urban Shanghai, China. SUBJECTS--9021 Chinese men and women aged 35-64 at baseline. MAIN OUTCOME MEASURE--Death from coronary heart disease and other causes. RESULTS--The average serum cholesterol concentration was 4.2 mmol/l at baseline examination, and only 43 (7%) of the deaths that occurred during 8-13 years of follow up were attributed to coronary heart disease. There was a strongly positive, and apparently independent, relation between serum cholesterol concentration and death from coronary heart disease (z = 3.47, p less than 0.001), and within the range of usual serum cholesterol concentration studied (3.8-4.7 mmol/l) there was no evidence of any threshold. After appropriate adjustment for the regression dilution bias, a 4 (SD 1)% difference in usual cholesterol concentration was associated with a 21 (SD 6)% (95% confidence interval 9% to 35%) difference in mortality from coronary heart disease. There was no significant relation between serum cholesterol concentration and death from stroke or all types of cancer. The 79 deaths due to liver cancer or other chronic liver disease were inversely related to cholesterol concentration at baseline. CONCLUSION--Blood cholesterol concentration was directly related to mortality from coronary heart disease even in those with what was, by Western standards, a "low" cholesterol concentration. There was no good evidence of an adverse effect of cholesterol on other causes of death.

Full text

PDF
282

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaglehole R., Foulkes M. A., Prior I. A., Eyles E. F. Cholesterol and mortality in New Zealand Maoris. Br Med J. 1980 Feb 2;280(6210):285–287. doi: 10.1136/bmj.280.6210.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dyer A. R., Stamler J., Paul O., Shekelle R. B., Schoenberger J. A., Berkson D. M., Lepper M., Collette P., Shekelle S., Lindberg H. A. Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies. J Chronic Dis. 1981;34(6):249–260. doi: 10.1016/0021-9681(81)90030-8. [DOI] [PubMed] [Google Scholar]
  3. Ederer F. Serum cholesterol changes: effects of diet and regression toward the mean. J Chronic Dis. 1972 May;25(5):277–289. doi: 10.1016/0021-9681(72)90164-6. [DOI] [PubMed] [Google Scholar]
  4. Feinleib M. On a possible inverse relationship between serum cholesterol and cancer mortality. Am J Epidemiol. 1981 Jul;114(1):5–10. doi: 10.1093/oxfordjournals.aje.a113173. [DOI] [PubMed] [Google Scholar]
  5. Goldbourt U., Holtzman E., Neufeld H. N. Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect. Br Med J (Clin Res Ed) 1985 Apr 27;290(6477):1239–1243. doi: 10.1136/bmj.290.6477.1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Isles C. G., Hole D. J., Gillis C. R., Hawthorne V. M., Lever A. F. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ. 1989 Apr 8;298(6678):920–924. doi: 10.1136/bmj.298.6678.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Iso H., Jacobs D. R., Jr, Wentworth D., Neaton J. D., Cohen J. D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989 Apr 6;320(14):904–910. doi: 10.1056/NEJM198904063201405. [DOI] [PubMed] [Google Scholar]
  8. Li S. C., Schoenberg B. S., Wang C. C., Cheng X. M., Bolis C. L., Wang K. J. Cerebrovascular disease in the People's Republic of China: epidemiologic and clinical features. Neurology. 1985 Dec;35(12):1708–1713. doi: 10.1212/wnl.35.12.1708. [DOI] [PubMed] [Google Scholar]
  9. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990 Mar 31;335(8692):765–774. doi: 10.1016/0140-6736(90)90878-9. [DOI] [PubMed] [Google Scholar]
  10. Muldoon M. F., Manuck S. B., Matthews K. A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ. 1990 Aug 11;301(6747):309–314. doi: 10.1136/bmj.301.6747.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pekkanen J., Nissinen A., Punsar S., Karvonen M. J. Serum cholesterol and risk of accidental or violent death in a 25-year follow-up. The Finnish cohorts of the Seven Countries Study. Arch Intern Med. 1989 Jul;149(7):1589–1591. [PubMed] [Google Scholar]
  12. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ragland D. R., Brand R. J. Coronary heart disease mortality in the Western Collaborative Group Study. Follow-up experience of 22 years. Am J Epidemiol. 1988 Mar;127(3):462–475. doi: 10.1093/oxfordjournals.aje.a114823. [DOI] [PubMed] [Google Scholar]
  14. Robertson T. L., Kato H., Rhoads G. G., Kagan A., Marmot M., Syme S. L., Gordon T., Worth R. M., Belsky J. L., Dock D. S. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol. 1977 Feb;39(2):239–243. doi: 10.1016/s0002-9149(77)80197-5. [DOI] [PubMed] [Google Scholar]
  15. Rose G., Shipley M. J. Plasma lipids and mortality: a source of error. Lancet. 1980 Mar 8;1(8167):523–526. doi: 10.1016/s0140-6736(80)92775-0. [DOI] [PubMed] [Google Scholar]
  16. Rose G., Shipley M. Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study. Br Med J (Clin Res Ed) 1986 Aug 2;293(6542):306–307. doi: 10.1136/bmj.293.6542.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Salonen J. T. Risk of cancer and death in relation to serum cholesterol. A longitudinal study in an eastern Finnish population with high overall cholesterol level. Am J Epidemiol. 1982 Oct;116(4):622–630. doi: 10.1093/oxfordjournals.aje.a113445. [DOI] [PubMed] [Google Scholar]
  18. Schatzkin A., Hoover R. N., Taylor P. R., Ziegler R. G., Carter C. L., Larson D. B., Licitra L. M. Serum cholesterol and cancer in the NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey. Lancet. 1987 Aug 8;2(8554):298–301. doi: 10.1016/s0140-6736(87)90890-7. [DOI] [PubMed] [Google Scholar]
  19. Sherwin R. W., Wentworth D. N., Cutler J. A., Hulley S. B., Kuller L. H., Stamler J. Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA. 1987 Feb 20;257(7):943–948. [PubMed] [Google Scholar]
  20. Szatrowski T. P., Peterson A. V., Jr, Shimizu Y., Prentice R. L., Mason M. W., Fukunaga Y., Kato H. Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort. J Chronic Dis. 1984;37(7):569–584. doi: 10.1016/0021-9681(84)90007-9. [DOI] [PubMed] [Google Scholar]
  21. Törnberg S. A., Holm L. E., Carstensen J. M., Eklund G. A. Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Engl J Med. 1986 Dec 25;315(26):1629–1633. doi: 10.1056/NEJM198612253152601. [DOI] [PubMed] [Google Scholar]
  22. Williams R. R., Sorlie P. D., Feinleib M., McNamara P. M., Kannel W. B., Dawber T. R. Cancer incidence by levels of cholesterol. JAMA. 1981 Jan 16;245(3):247–252. [PubMed] [Google Scholar]
  23. Yano K., Reed D. M., McGee D. L. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. Am J Epidemiol. 1984 May;119(5):653–666. doi: 10.1093/oxfordjournals.aje.a113787. [DOI] [PubMed] [Google Scholar]
  24. ZAK B., DICKENMAN R. C., WHITE E. G., BURNETT H., CHERNEY P. J. Rapid estimation of free and total cholesterol. Am J Clin Pathol. 1954 Nov;24(11):1307–1315. doi: 10.1093/ajcp/24.11_ts.1307. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES